Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! Download free report on life science investment in China.

News & Analysis

China biotech company and industry news and analysis...

Fosun Enters $125 Million China Deal for Ardelyx IBS Treatment
Week in Review: China Life Science Deals Total $550 Million
China Investor Syndicate Acquires Esaote, an Italian Imaging Device Company
Shenzhen BioScien Acquires China Rights to Generex Cancer Vaccine
BGI Genomics Partners with Sanguine to Build Databases of Clinical Trial Patients
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China